BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 26, 2025
Home » Authors » John Fox

Articles by John Fox

Epigenetic mechanisms can contribute to resistance in melanoma

July 10, 2018
By John Fox

A study by scientists at New Zealand's Otago University has opened the door to the discovery of new biomarkers that potentially predict whether melanoma patients will respond to treatment with novel checkpoint inhibitor immunotherapies.


Read More

Epigenetic mechanisms can contribute to resistance in melanoma for patients

July 6, 2018
By John Fox

Epigenetic mechanisms can contribute to resistance in melanoma

July 6, 2018
By John Fox
A study by scientists at New Zealand's Otago University has opened the door to the discovery of new biomarkers that potentially predict whether melanoma patients will respond to treatment with novel checkpoint inhibitor immunotherapies.
Read More

Cell death discovery paves way for new treatments

July 5, 2018
By John Fox
The discovery of how human cells are triggered to undergo cell death could have major implications for development of new drugs for treating cancer, stroke and tissue injury, and immune disorders, according to a study by Australian researchers.
Read More

Cell death discovery paves way for new treatments

July 5, 2018
By John Fox
The discovery of how human cells are triggered to undergo cell death could have major implications for development of new drugs for treating cancer, stroke and tissue injury, and immune disorders, according to a study by Australian researchers.
Read More

Cell death discovery paves way for new treatments

July 2, 2018
By John Fox

First new influenza drug developed using viral genes

June 27, 2018
By John Fox
HONG KONG – A team of researchers from the University of Hong Kong (HKU) has developed a novel strategy for the prevention and treatment of influenza virus infection, which they then demonstrated to be effective in mice.
Read More

Mutation links bipolar disorder to mitochondrial dysfunction

June 20, 2018
By John Fox
Mutations in the adenine nucleotide translocase type 1 (ANT1) gene may confer a risk for bipolar disorder through a complex interaction between serotonin and mitochondri al signaling within the brain, a new Japanese study suggests.
Read More

Mutation links bipolar disorder to mitochondrial dysfunction

June 15, 2018
By John Fox

Mutation links bipolar disorder to mitochondrial dysfunction

June 15, 2018
By John Fox
Mutations in the adenine nucleotide translocase type 1 (ANT1) gene may confer a risk for bipolar disorder through a complex interaction between serotonin and mitochondrial signaling within the brain, a new Japanese study suggests.
Read More
Previous 1 2 … 20 21 22 23 24 25 26 27 28 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing